Toshiba, under its new five-year business strategy, has developed a technology that uses microRNA molecules in the blood to detect cancer. The company has come up with a new technology that can detect 13 different types of cancer with 99 percent accuracy in less than 2 hours. Using a chip and a small device to conduct the diagnosis and it will cost $180 per test that can be used to efficiently detect different kinds of cancer cells.
Toshiba collaborated with the National Cancer Center Research Institute and Tokyo Medical University for the project and is hoping to commercialize it within a few years. Currently, the company is planning to begin trials next year.
Source: Pro Pakistani